» Articles » PMID: 21104073

Restless Legs Syndrome Due to Aripiprazole

Overview
Specialty Pharmacology
Date 2010 Nov 25
PMID 21104073
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Aripiprazole, a Novel Option in the Management of Restless Legs Syndrome (RLS) Patients with Augmentation and/or Severe RLS Symptoms: A Report of 4 Cases.

Lee E, Spitale N, Robillard R Nat Sci Sleep. 2023; 15:779-784.

PMID: 37818170 PMC: 10561607. DOI: 10.2147/NSS.S421189.


Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease.

Faulkner M CNS Drugs. 2018; 32(2):149-159.

PMID: 29480463 DOI: 10.1007/s40263-018-0502-z.


Review of the treatment of restless legs syndrome: focus on gabapentin enacarbil.

Burke R, Faulkner M J Cent Nerv Syst Dis. 2013; 4:147-56.

PMID: 23650473 PMC: 3619699. DOI: 10.4137/JCNSD.S9107.

References
1.
Khalid I, Rana L, Khalid T, Roehrs T . Refractory restless legs syndrome likely caused by olanzapine. J Clin Sleep Med. 2009; 5(1):68-9. PMC: 2637170. View

2.
Kang S, Lee H, Kim L . Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine. J Psychopharmacol. 2008; 23(5):597-601. DOI: 10.1177/0269881108091876. View

3.
Bahk W, Pae C, Chae J, Jun T, Kim K . Mirtazapine may have the propensity for developing a restless legs syndrome? A case report. Psychiatry Clin Neurosci. 2002; 56(2):209-10. DOI: 10.1046/j.1440-1819.2002.00955.x. View

4.
Allen R, Earley C . Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001; 18(2):128-47. DOI: 10.1097/00004691-200103000-00004. View

5.
Nichols D, Allen R, Grauke J, Brown J, Rice M, Hyde P . Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med. 2003; 163(19):2323-9. DOI: 10.1001/archinte.163.19.2323. View